231 related articles for article (PubMed ID: 22594946)
1. Neuropeptide Y loses its orexigenic effect in rats with lesions of the hypothalamic paraventricular nucleus.
Wang J; Yuan Z; Dong J; Zhang D; Usami T; Murata T; Narita K; Higuchi T
Endocr Res; 2013; 38(1):8-14. PubMed ID: 22594946
[TBL] [Abstract][Full Text] [Related]
2. Effects of ghrelin, corticotrophin-releasing hormone, and melanotan-II on food intake in rats with paraventricular nucleus lesions.
Wang J; Ling S; Usami T; Murata T; Narita K; Higuchi T
Exp Clin Endocrinol Diabetes; 2007 Nov; 115(10):669-73. PubMed ID: 18058602
[TBL] [Abstract][Full Text] [Related]
3. The hypothalamic paraventricular nucleus is not essential for orexigenic NPY or anorexigenic melanocortin action.
Dube MG; Kalra SP; Kalra PS
Peptides; 2006 Sep; 27(9):2239-48. PubMed ID: 16759748
[TBL] [Abstract][Full Text] [Related]
4. Agmatine in the hypothalamic paraventricular nucleus stimulates feeding in rats: involvement of neuropeptide Y.
Taksande BG; Kotagale NR; Nakhate KT; Mali PD; Kokare DM; Hirani K; Subhedar NK; Chopde CT; Ugale RR
Br J Pharmacol; 2011 Sep; 164(2b):704-18. PubMed ID: 21564088
[TBL] [Abstract][Full Text] [Related]
5. Ghrelin acts on rat dorsal vagal complex to stimulate feeding via arcuate neuropeptide Y/agouti-related peptide neurons activation.
Guan HZ; Li QC; Jiang ZY
Sheng Li Xue Bao; 2010 Aug; 62(4):357-64. PubMed ID: 20717637
[TBL] [Abstract][Full Text] [Related]
6. Nicotine and its withdrawal alter feeding induced by paraventricular hypothalamic injections of neuropeptide Y in Sprague-Dawley rats.
Bishop C; Parker GC; Coscina DV
Psychopharmacology (Berl); 2002 Jul; 162(3):265-72. PubMed ID: 12122484
[TBL] [Abstract][Full Text] [Related]
7. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226.
Kask A; Rägo L; Harro J
Br J Pharmacol; 1998 Aug; 124(7):1507-15. PubMed ID: 9723965
[TBL] [Abstract][Full Text] [Related]
8. Anorectic effects of estrogen may be mediated by decreased neuropeptide-Y release in the hypothalamic paraventricular nucleus.
Bonavera JJ; Dube MG; Kalra PS; Kalra SP
Endocrinology; 1994 Jun; 134(6):2367-70. PubMed ID: 8194462
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of neuropeptide Y (NPY)-induced feeding and c-Fos response in magnocellular paraventricular nucleus by a NPY receptor antagonist: a site of NPY action.
Yokosuka M; Kalra PS; Kalra SP
Endocrinology; 1999 Oct; 140(10):4494-500. PubMed ID: 10499503
[TBL] [Abstract][Full Text] [Related]
10. Activation of hypothalamic NPY, AgRP, MC4R, AND IL-6 mRNA levels in young Lewis rats with early-life diet-induced obesity.
Stofkova A; Skurlova M; Kiss A; Zelezna B; Zorad S; Jurcovicova J
Endocr Regul; 2009 Jul; 43(3):99-106. PubMed ID: 19817504
[TBL] [Abstract][Full Text] [Related]
11. Altered neuropeptide Y effects on noradrenaline levels in the paraventricular nucleus of rats following aortic constriction.
Woo ND; Ganguly PK
Can J Cardiol; 1994 May; 10(4):471-6. PubMed ID: 8193992
[TBL] [Abstract][Full Text] [Related]
12. [A neuroendocrinological study on the mechanism of feeding-associated circadian rhythm of plasma corticosterone and feeding behaviour in rats: a role of neuropeptide Y in the paraventricular nucleus].
Yoshihara T
Hokkaido Igaku Zasshi; 1995 Jan; 70(1):113-31. PubMed ID: 7744361
[TBL] [Abstract][Full Text] [Related]
13. Increased feeding and neuropeptide Y (NPY) but not NPY mRNA levels in the hypothalamus of the rat following central administration of the serotonin synthesis inhibitor p-chlorophenylalanine.
Dryden S; Frankish HM; Wang Q; Williams G
Brain Res; 1996 Jun; 724(2):232-7. PubMed ID: 8828573
[TBL] [Abstract][Full Text] [Related]
14. Disruption in neuropeptide Y and leptin signaling in obese ventromedial hypothalamic-lesioned rats.
Dube MG; Xu B; Kalra PS; Sninsky CA; Kalra SP
Brain Res; 1999 Jan; 816(1):38-46. PubMed ID: 9878684
[TBL] [Abstract][Full Text] [Related]
15. Feeding and drinking responses to neuropeptide Y injections in the paraventricular hypothalamic nucleus of aged rats.
Pich EM; Messori B; Zoli M; Ferraguti F; Marrama P; Biagini G; Fuxe K; Agnati LF
Brain Res; 1992 Mar; 575(2):265-71. PubMed ID: 1571785
[TBL] [Abstract][Full Text] [Related]
16. Insulin and insulin-like growth factor II suppress neuropeptide Y release from the nerve terminals in the paraventricular nucleus: a putative hypothalamic site for energy homeostasis.
Sahu A; Dube MG; Phelps CP; Sninsky CA; Kalra PS; Kalra SP
Endocrinology; 1995 Dec; 136(12):5718-24. PubMed ID: 7588328
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y release from the paraventricular nucleus increases in association with hyperphagia in streptozotocin-induced diabetic rats.
Sahu A; Sninsky CA; Phelps CP; Dube MG; Kalra PS; Kalra SP
Endocrinology; 1992 Dec; 131(6):2979-85. PubMed ID: 1446635
[TBL] [Abstract][Full Text] [Related]
18. Sustained NPY overexpression in the PVN results in obesity via temporarily increasing food intake.
Tiesjema B; la Fleur SE; Luijendijk MC; Adan RA
Obesity (Silver Spring); 2009 Jul; 17(7):1448-50. PubMed ID: 19553928
[TBL] [Abstract][Full Text] [Related]
19. Functional impairment of hypothalamic corticotropin-releasing factor neurons with immunotargeted toxins enhances food intake induced by neuropeptide Y.
Menzaghi F; Heinrichs SC; Pich EM; Tilders FJ; Koob GF
Brain Res; 1993 Jul; 618(1):76-82. PubMed ID: 8402180
[TBL] [Abstract][Full Text] [Related]
20. Dissociated feeding and hypothermic effects of neuropeptide Y in the paraventricular and perifornical hypothalamus.
Currie PJ; Coscina DV
Peptides; 1995; 16(4):599-604. PubMed ID: 7479290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
